Home » Topics » Regulatory » Patents

Patents
RSS

New targets and treatments reported for psychosis, depression, etc.

Aug. 4, 2005

Novel analgesic agents claimed in recent patent literature

Aug. 4, 2005

Novel agents disclosed for the treatment of diabetes and related disorders

Aug. 3, 2005

Dompe patent claims novel chemokine CXCR1/CXCR2 receptor antagonists

Aug. 3, 2005

Therapeutic agents for respiratory and inflammatory disorders in early development

Aug. 3, 2005

Novel HMG-CoA reductase inhibitors for lipoprotein disorders emerge from Bristol-Myers Squibb R&D

Aug. 2, 2005

PAI-1 inhibitors in early development at Wyeth for thrombotic disorders

Aug. 2, 2005

Novel therapeutics identified for neurological disorders

Aug. 2, 2005

Recent patents describe novel antiinfective agents

Aug. 1, 2005

Novel TACE inhibitors claimed in recent patent literature

Aug. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...